Elon Musk’s Neuralink receives FDA’s ‘breakthrough device’ status for ‘Blindsight’ implant
Elon Musk’s brain chip firm Neuralink has received “breakthrough device” status for an implant aimed at helping blind patients regain their sight, the firm announced Wednesday. Dubbed “Blindsight,” the experimental brain implant gained clearance from the US Food and Drug Administration to participate in the voluntary program. It is one of 58 devices to receive … Read more